《美國股市》道指收市飆524點 納指揚2.4%跑出
Meta(META.US)首季業績及今年盈測強勁,周四(27日)股價飆升13.9%,提振科技股及推高納指,納指最終跑贏道指及標普500指鷜,高收287.89點或2.43%,報12,142.24點。
道指高收524.29點或1.57%,報33,826.16點;標普500指數高收79.36點或1.96%,報4,135.35點。
受Meta推動,亞馬遜飆4.6%;Alphabet(GOOG.US)升3.8%;微軟(MSFT.US)升3.2%;蘋果(AAPl.US)升2.8%。
作為全球經濟晴雨表的Caterpillar(CAT.US)公布首季業績,該股跌幅收窄,最終收市跌0.9%。(me/e)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.